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Background
Evidence that psychological stress can contribute to the 
development and progression of cancer has accumulated 
over the past several decades, but the mechanisms res-
ponsible remain obscure [1-5]. A comprehensive meta-
analysis of 165 longitudinal studies concluded that 
psycho social factors are associated with higher incidence, 
poorer survival and increased mortality [6]. Psychological 
stress activates the hypothalamic–pituitary–adrenal axis 
and the sympathetic nervous system, resulting in 
systemic increases in cortisol and catecholamines. Th e 
eﬀ ects of catecholamines are mediated by nine distinct α-
adrenergic and β-adrenergic G-protein-coupled recep tors, 
which are present on a wide range of cell types, including 
cancer cells [7].
One underappreciated possible mechanism for stress 
eﬀ ects on cancer is suggested by emerging evidence that 
DNA damage is increased by exposure to stress and 
stress hormones [8,9]. Indeed, a recent report has 
documented that β-adrenergic stimulation can cause 
DNA damage suﬃ  cient to promote transformation and 
tumorigenicity of mouse 3T3 cells [10]. Currently, 
however, little is known about the molecular pathways 
responsible for stress-induced DNA damage. A recent 
report in Nature has provided evidence that accumu-
lation of DNA damage following chronic adrenergic 
stimulation (for example, as a result of chronic stress) 
may be the result of synergistic eﬀ ects of β-adrenergic 
stimulation on two molecular pathways  – one directly 
leading to DNA damage, the other leading to a reduction 
in p53 levels [11].
The article
Using a mouse model, Hara and colleagues simulated 
chronic stress by prolonged pharmacological stimulation 
of β2-receptors with the β-adrenergic agonist iso pro-
terenol, a synthetic analogue of adrenaline [11]. Th e 
investi gators ﬁ rst demonstrated that chronic catechol-
amine stimulation leads to phosphorylation of histone 
H2AX, one of the earliest indicators of DNA damage.
Using a speciﬁ c β2-antagonist, they then determined 
that the increased DNA damage occurred as a result of 
nuclear export and p53 degradation through receptor-
speciﬁ c mechanisms. Murine double minute 2 (MDM2) 
plays an important role in p53 nuclear export and 
degradation. In light of this fact, the authors were able – 
using a com bination of receptor antagonists and phos-
pho inositide 3-kinase and AKT inhibitors  – to demon-
strate that β2-adrenoreceptor activation resulted in MDM2 
phos phory lation via the phosphoinositide 3-kinase/AKT 
cascade and accumulation of DNA damage in wild-type 
mouse embryonic ﬁ broblasts. Th ey further found that 
arrestin beta 1 (ARRB1), which functions as an E3 ligase 
adaptor for MDM2 and p53, facilitated catecholamine-
induced p53 degradation by MDM2. β-adrenergic 
stimulation of the phosphoinositide 3-kinase/AKT 
cascade can be stimulated by both the Gs–protein kinase 
A and the β-arrestin-mediated signaling pathways. Th rough 
the application of H-89, a protein kinase A inhibitor, and 
use of ARRB1-knockout or ARRB2-knockout mouse 
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embryonic ﬁ broblasts, the authors demonstrated that 
chronic catecholamine stimulation leads to accumulation 
of DNA damage by an ARRB1-dependent and p53-
dependent mechanism.
In summary, Hara and colleagues provided evidence 
that catecholamines can act through two pathways: via 
Gs–protein kinase A, and via ARRB1 inducing DNA 
damage [11]. Both pathways are activated as a result of 
stimulation of β2-adrenoreceptors, with the ARBB1 
facilitating AKT-mediated activation of murine double 
minute, which in turn promotes MDM2 to bind and 
degrade p53, leading to the accumulation of DNA 
damage (Figure 1).
The viewpoint
DNA damage triggers a number of cellular responses, 
including repair mechanisms, cell-cycle checkpoint 
activity and apoptosis. Th e tumor suppressor protein that 
mediates many of these critical cellular functions (p53) is 
frequently mutated, and has been found to be inactivated 
or functionally downregulated in breast cancer. Th e 
upstream mechanisms that regulate p53 degradation and 
accumulation of DNA damage, which Hara and 
colleagues have described, could thus have signiﬁ cant 
implications. Indeed, in precancerous 3T3 cells, stress 
hormones can cause induction of the DNA damage 
sensors Chk1 and Chk2, MDM2, and the protooncogene 
CDC25A, which is involved in cell-cycle delay following 
DNA damage, resulting in increased cell transformation 
[8]. Although the literature has come a long way towards 
recognizing the potential importance of psychological 
stress in the initiation and progression of breast cancer 
[12], few studies have explored the mechanisms through 
which stress hormones may impact breast cancer 
initia tion and progression. It is tempting to speculate that 
increases in stress hormones could promote DNA 
damage and inhibit countervailing processes, and thus 
lead to a predisposition to breast cancer.
Also, if stress hormones can induce DNA damage in 
breast cancer, could this damage contribute to diﬀ erences 
in the eﬃ  cacy of chemotherapy drugs across individuals 
as a result of diﬀ erences in their stress levels? Such 
personalized stress eﬀ ects could have i mportant 
implications for cancer therapeutic strategies that are 
based on the induction of DNA damage in rapidly 
dividing cells. For example, in breast cancer cells treated 
with anthra cy clines – which work through intercalation 
of DNA and subsequent DNA damage – would 
heightened levels of catecholamines actually beneﬁ t 
chemotherapy? Would stress-induced DNA damage 
impact drugs that work through other mechanisms, such 
as Taxol? Clearly, there is a need for further mechanistic 
studies to explore the eﬀ ects of stress hormones on DNA 
damage pathways involved in breast cancer etiology and 
in response to chemotherapy treatment.
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Figure 1. Schematic diagram of catecholamine-induced eff ects 
on DNA damage during chronic stress. β2AR, β2-adrenoreceptor; 
ARRB1, arrestin beta 1; MDM2, murine double minute 2; PKA, protein 
kinase A; PI3K, phosphoinositide 3-kinase. Based on [11].
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